High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor?

Critical Care Medicine

Volumn 32, Issue 3, 2004, Pages 734-739

  Chuang, Chia Chang ^a   Hung, Chung Jye ^a   Tsai, Ming Che ^a   Yeh, Tria Ming ^a   Chuang, Yin Ching ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Acute Physiology and Chronic Health Evaluation II; Macrophage migration inhibitory factor; Postinjury sepsis; Severe blunt trauma; Systemic inflammatory response syndrome

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BLUNT TRAUMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; APACHE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; OBSERVATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TAIWAN; WOUNDS, NONPENETRATING;

EID: 1542614333     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000117170.13320.F4     Document Type: Article

References (31)

1. Baugh JA, Bucala R: Macrophage migration inhibitory factor. Crit Care Med 2002; 30:S27-S35
2. Calandra T, Bernhagen J, Mitchell RA, et al: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179:1895-1902
3. Calandra T, Spiegel LA, Metz CN, et al: Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA 1998; 95:11383-11388
4. Bernhagen J, Calandra T, Butala R: Regulation of the immune response by macrophage migration inhibitory factor: Biological and structural features. J Mol Med 1998; 76:151-161
5. Donnelly SC, Haslett C, Reid PT, et al: Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3:320-323
6. Joshi PC, Poole GV, Sachdev V, et al: Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF). Res Commun Mol Pathol Pharmacol 2000; 107:13-20
7. Beishuizen A, Thijs LG, Haanen C, et al: Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001; 86:2811-2816
8. Hoch RC, Rodriguez R, Manning T, et al: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21:839-845
9. Stahl GL, Craft DV, Lento PH, et al: Detection of platelet-activating factor during traumatic shock. Circ Shock 1988; 26:237-244
10. Patrick DA, Moore FA, Moore EE, et al: The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 1996; 172:425-431
11. Ogata M, Okamoto K, Kohriyama K, et al: Role of interleukin-10 on hyporesponsiveness of endotoxin during surgery. Crit Care Med 2000; 28:3166-3170
12. Knaus WA, Draper EA, Wagner DP, et al: A PACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-827
13. Baker SP, O'Neill B, Haddon W, et al: The Injury Severity Score: A method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14:187-196
14. Champion HR, Sacco WJ, Copes WS, et al: A revision of the trauma score. J Trauma 1989; 29:623-629
15. Boyd CR, Tolson MA, Copes WS: Evaluating trauma care: The TRISS method. J Trauma 1987; 27:370-378
16. Hou LF, Tsai MC: Comparison between TRISS and ASCOT methods in Tainan area. Kaohsiung J Med Sci 1996; 12:691-698
17. Castella X, Artigas A, Bion J, et al: A comparison of severity of illness scoring systems for intensive care unit patients: Results of a multicenter, multinational study. Crit Care Med 1995; 23:1327-1335
18. Sauaia A, Moore FA, Moore EE, et al: Early predictors of postinjury multiple organ failure. Arch Surg 1994; 129:39-45
19. Lue H, Kleemann R, Calandra T, et al: Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease. Microbes Inf 2002; 4:449-460
20. Orita M, Yamamoto S, Katayama N, et al: Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors. Curr Pharm Des 2002; 8:1297-1317
21. Calandra T, Echtenacher B, Roy DL, et al: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6:164-170
22. Calandra T, Bernhagen J, Metz CN, et al: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377:68-71
23. Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin 1, 2 and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 1994; 36:336-340
24. Neidhardt R, Keel M, Steckholzer U, et al: Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997; 42:863-871
25. Whalen MJ, Carlos TM, Kochanek PM, et al: Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med 2000; 28:929-934
26. Cinat ME, Waxman K, Granger GA, et al: Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg 1994; 179:529-537
27. Calandra T, Roger T: Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 2003; 3:791-800
28. Bucala R: MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 1996; 10:1607-1613
29. Yu CM, Lai KWH, Chen YX, et al: Expression of macrophage migration inhibitory factor in acute ischemic myocardial injury. J Histochem Cytochem 2003; 51:625-631
30. Abraham E: Host defense abnormalities after hemorrhage, trauma, and burns. Crit Care Med 1989; 17:934-939
31. Muehlstedt SG, Richardson C, Lyte M, et al: Systemic and pulmonary effector cell function after injury. Crit Care Med 2002; 30:1322-1326